这是一篇来自已证抗体库的有关斑马鱼 map1lc3b的综述,是根据140篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合map1lc3b 抗体。
map1lc3b 同义词: Map1lc3; wu:fb60g11; zgc:56434
Novus Biologicals
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100)被用于被用于免疫印迹在小鼠样本上 (图 4a, 4b). Nat Commun (2022) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在小鼠样本上 (图 3d, 8b) 和 被用于免疫印迹在人类样本上 (图 1d). Acta Pharm Sin B (2022) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 2e) 和 被用于免疫印迹在人类样本上浓度为1:500 (图 4d). Cell Prolif (2021) ncbi |
domestic rabbit 多克隆(OTI2B3) |
| Novus Biologicals map1lc3b抗体(Novus, NB600-1384)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4c). Cell Death Dis (2021) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 4b) 和 被用于免疫印迹在大鼠样本上 (图 1d). Front Pharmacol (2021) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在小鼠样本上. Cells (2021) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在小鼠样本上 (图 1g). Cells (2021) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 2c). J Cachexia Sarcopenia Muscle (2021) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6a). Nat Commun (2021) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 1d). Stem Cell Reports (2021) ncbi |
domestic rabbit 多克隆(OTI2B3) |
| Novus Biologicals map1lc3b抗体(Novus, NB600-1384)被用于被用于免疫组化在小鼠样本上 (图 s8j). Nat Neurosci (2021) ncbi |
domestic rabbit 多克隆(OTI2B3) |
| Novus Biologicals map1lc3b抗体(Novus, NB600-1384)被用于被用于免疫印迹在小鼠样本上 (图 1e). Cell Death Differ (2021) ncbi |
domestic rabbit 多克隆(OTI2B3) |
| Novus Biologicals map1lc3b抗体(NOVUS Biologicals, NB600-1384)被用于被用于免疫细胞化学在小鼠样本上 (图 5c) 和 被用于免疫印迹在小鼠样本上 (图 5c). Aging (Albany NY) (2021) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在小鼠样本上浓度为1:3000 (图 2i). Nat Commun (2021) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1l). Commun Biol (2021) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上浓度为1:2000. Nature (2021) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 1a). EMBO Rep (2020) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫细胞化学在小鼠样本上 (图 1c). Nat Commun (2020) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在小鼠样本上 (图 s3a). Nat Commun (2020) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biotechnology, NB1002220)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4a). Antioxidants (Basel) (2020) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫组化-自由浮动切片在小鼠样本上浓度为1:500 (图 2e) 和 被用于免疫印迹在小鼠样本上浓度为1:5000 (图 2a). Autophagy (2021) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 4a). Cell Death Dis (2020) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(NOVUS Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 2a). Autophagy (2020) ncbi |
domestic rabbit 多克隆(OTI2B3) |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB600-1384)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5s2b). elife (2020) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在小鼠样本上 (图 2a). Cell Death Dis (2019) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(NOVUS, NB100-2220)被用于被用于免疫细胞化学在人类样本上 (图 s2a) 和 被用于免疫印迹在人类样本上 (图 2a). Sci Adv (2019) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在小鼠样本上浓度为1:20,000 (图 6h). Autophagy (2019) ncbi |
domestic rabbit 多克隆(OTI2B3) |
| Novus Biologicals map1lc3b抗体(Novus, NB600-1384)被用于被用于免疫印迹在人类样本上 (图 5a). Nucleic Acids Res (2019) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100?C2220)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1c). J Clin Invest (2019) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 2a). J Cancer (2019) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, 100-2220)被用于被用于免疫印迹在人类样本上 (图 3g). Front Mol Neurosci (2019) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 8c). Nat Commun (2019) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 5a). Autophagy (2019) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在豚鼠样本上 (图 7b). Biomed Res Int (2019) ncbi |
domestic rabbit 多克隆(OTI2B3) |
| Novus Biologicals map1lc3b抗体(Novus, NB600-1384)被用于被用于免疫印迹在人类样本上 (图 4b). Oncogene (2019) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 1a). Autophagy (2018) ncbi |
domestic rabbit 多克隆(OTI2B3) |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB600-1384)被用于被用于免疫印迹在小鼠样本上 (图 s8d). J Clin Invest (2018) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 3c). PLoS ONE (2018) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上浓度为1:3000 (图 1b). Nat Commun (2018) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 2a). Front Immunol (2018) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 6a). Cell Death Differ (2018) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biological, NB100-2220)被用于被用于免疫印迹在小鼠样本上浓度为1:3000 (图 4b). J Lipid Res (2018) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 5g). Nat Commun (2017) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在小鼠样本上 (图 2f). J Clin Invest (2017) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在小鼠样本上 (图 2c). PLoS Genet (2017) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 1f). J Biol Chem (2017) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在小鼠样本上 (图 2c). Cell Immunol (2017) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB 100-2220)被用于被用于免疫印迹在小鼠样本上 (图 1a) 和 被用于免疫印迹在人类样本上 (图 e4d). Nature (2017) ncbi |
domestic rabbit 多克隆(OTI2B3) |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB600-1384)被用于被用于免疫组化在大鼠样本上浓度为1:200 (图 3) 和 被用于免疫印迹在大鼠样本上浓度为1:1000 (图 1a). Am J Transl Res (2017) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB 100-2220)被用于被用于免疫印迹在斑马鱼样本上 (图 3d) 和 被用于免疫印迹在人类样本上 (图 5b). Cell Chem Biol (2017) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4d). Nat Commun (2017) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 8c). J Nutr Biochem (2017) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-222055)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 5a). Cell Rep (2017) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 1b). Cell (2017) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上浓度为1:3000 (图 3a). Nat Commun (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB00-2220)被用于被用于免疫印迹在小鼠样本上 (图 3d). JCI Insight (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1f). EMBO Rep (2017) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 1h). Oncotarget (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 5a). J Cell Biol (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在小鼠样本上 (图 3f). Autophagy (2017) ncbi |
domestic rabbit 多克隆(OTI2B3) |
| Novus Biologicals map1lc3b抗体(Novus, NB600-1384)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3a). J Huntingtons Dis (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NN100-2220)被用于被用于免疫组化在人类样本上 (图 5a). J Transl Med (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus biological, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 5b). Front Cell Infect Microbiol (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在大鼠样本上浓度为1:1000. Mol Genet Metab (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(NovusBio, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 4e). Autophagy (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 1e). Oncotarget (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在小鼠样本上浓度为1:5000 (图 6). PLoS ONE (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 3). elife (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫细胞化学在人类样本上 (图 3) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 3). Drug Des Devel Ther (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上. Autophagy (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫细胞化学在人类样本上浓度为1:400 (图 2d) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 5b). Nat Commun (2016) ncbi |
domestic rabbit 多克隆(OTI2B3) |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, 600-1384)被用于被用于免疫印迹在人类样本上 (图 5). J Immunol (2016) ncbi |
domestic rabbit 多克隆(OTI2B3) |
| Novus Biologicals map1lc3b抗体(Novusbio, NB600-1384)被用于被用于免疫印迹在人类样本上 (图 6). Neurobiol Dis (2016) ncbi |
domestic rabbit 多克隆(OTI2B3) |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB600-1384)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:4000 (图 3) 和 被用于免疫印迹在人类样本上 (图 1a). Oncotarget (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1a). J Pharmacol Exp Ther (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 4b). Oncotarget (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫细胞化学在小鼠样本上 (图 7), 被用于免疫印迹在小鼠样本上 (图 1) 和 被用于免疫印迹在大鼠样本上 (图 10). Autophagy (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biological, NB100-2220)被用于被用于免疫印迹在小鼠样本上 (图 6). Autophagy (2016) ncbi |
domestic rabbit 多克隆(OTI2B3) |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB600-1384)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2). elife (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 6). J Nanobiotechnology (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在斑马鱼样本上浓度为1:2000 (图 s2). Hum Mol Genet (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在小鼠样本上. Sci Rep (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB 100-2220)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 s1). Nat Commun (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在人类样本上 (图 3). J Neurosci (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 1). Oncotarget (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 3). J Cell Sci (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 7). Traffic (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:100 (图 2e). J Mol Cell Cardiol (2016) ncbi |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于. Cell Death Dis (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biological, NB100?C2220)被用于. Sci Rep (2015) ncbi | |
domestic rabbit 多克隆(OTI2B3) | Novus Biologicals map1lc3b抗体(Novus, NB600-1384)被用于. Mol Pharmacol (2015) ncbi | |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500 (图 s4b). Kidney Int (2016) ncbi |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220SS)被用于. Autophagy (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于. PLoS ONE (2015) ncbi | |
domestic rabbit 多克隆(OTI2B3) | Novus Biologicals map1lc3b抗体(Novus, NB600-1384)被用于. PLoS ONE (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biological, NB-100-2220)被用于. Oncotarget (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220SS)被用于. Oncotarget (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于. Nat Commun (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于. Biochim Biophys Acta (2015) ncbi | |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus Biologicals, 100-2220)被用于被用于免疫印迹在人类样本上 (图 2). Leukemia (2016) ncbi |
domestic rabbit 多克隆 |
| Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于被用于免疫印迹在大鼠样本上 (图 5). Nutr Neurosci (2016) ncbi |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于. Sci Rep (2015) ncbi | |
domestic rabbit 多克隆(OTI2B3) | Novus Biologicals map1lc3b抗体(Novus Biologicals;, NB600- 1384)被用于. Nature (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于. Life Sci (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于. PLoS Pathog (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, 100-2220)被用于. PLoS ONE (2015) ncbi | |
domestic rabbit 多克隆(OTI2B3) | Novus Biologicals map1lc3b抗体(Novus, NB600-1384)被用于. Nat Cell Biol (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于. Cell Signal (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(novus Biologicals, NB100-2220)被用于. Nat Commun (2015) ncbi | |
domestic rabbit 多克隆(OTI2B3) | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB600-1384)被用于. Nat Commun (2015) ncbi | |
domestic rabbit 多克隆(OTI2B3) | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB600-1384)被用于. Exp Neurol (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于. Autophagy (2015) ncbi | |
domestic rabbit 多克隆(OTI2B3) | Novus Biologicals map1lc3b抗体(Novus, NB600-1384)被用于. Toxicol Lett (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于. Nat Neurosci (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于. J Neurosci (2015) ncbi | |
domestic rabbit 多克隆(OTI2B3) | Novus Biologicals map1lc3b抗体(Novus, NB600-1384)被用于. Nat Genet (2015) ncbi | |
domestic rabbit 多克隆(OTI2B3) | Novus Biologicals map1lc3b抗体(Novus, NB600-1384)被用于. Oncogene (2015) ncbi | |
domestic rabbit 多克隆(OTI2B3) | Novus Biologicals map1lc3b抗体(Novus, NB600-1384)被用于. Sci Signal (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于. Nat Cell Biol (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于. Autophagy (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于. Autophagy (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biologicals, NB100-2220)被用于. Autophagy (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus Biological, NB100-2220)被用于. Autophagy (2015) ncbi | |
domestic rabbit 多克隆(OTI2B3) | Novus Biologicals map1lc3b抗体(novus Biologicals, NB600-1384)被用于. Autophagy (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(NOVUS Biologicals, NB100-2220)被用于. PLoS ONE (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于. J Biol Chem (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于. Cell Death Dis (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于. J Clin Invest (2015) ncbi | |
domestic rabbit 多克隆 | Novus Biologicals map1lc3b抗体(Novus, NB100-2220)被用于. Nucleic Acids Res (2015) ncbi |
赛默飞世尔
domestic rabbit 多克隆 | 赛默飞世尔 map1lc3b抗体(Thermo Fisher, PA1-16930)被用于. Nature (2018) ncbi | |
domestic rabbit 多克隆 |
| 赛默飞世尔 map1lc3b抗体(Pierce, PA1-16931)被用于被用于免疫印迹在人类样本上 (图 4a). Oxid Med Cell Longev (2016) ncbi |
domestic rabbit 多克隆 |
| 赛默飞世尔 map1lc3b抗体(Thermo Scientific, PA1-C16,931)被用于被用于免疫印迹在大鼠样本上 (图 8). J Nutr Biochem (2016) ncbi |
domestic rabbit 多克隆 |
| 赛默飞世尔 map1lc3b抗体(Thermo Fisher Scientific, PA1-16931)被用于被用于免疫印迹在人类样本上 (图 s2a). Oncotarget (2016) ncbi |
domestic rabbit 多克隆 |
| 赛默飞世尔 map1lc3b抗体(Thermo Scientific, PA1-16930)被用于被用于免疫印迹在牛样本上浓度为1:500 (图 1). J Dairy Sci (2016) ncbi |
domestic rabbit 多克隆 |
| 赛默飞世尔 map1lc3b抗体(Thermo Scientific, PA1-16930)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3). J Cell Sci (2016) ncbi |
domestic rabbit 多克隆 | 赛默飞世尔 map1lc3b抗体(Thermo Scientific, PA1-C16930)被用于. Autophagy (2015) ncbi | |
domestic rabbit 多克隆 | 赛默飞世尔 map1lc3b抗体(Thermo, PA116931)被用于. Sci Rep (2015) ncbi | |
domestic rabbit 多克隆 | 赛默飞世尔 map1lc3b抗体(Thermo Scientific, PA1-46286)被用于. Biol Reprod (2015) ncbi | |
domestic rabbit 多克隆 | 赛默飞世尔 map1lc3b抗体(Thermo, PA5-22731)被用于. Oncotarget (2015) ncbi | |
domestic rabbit 多克隆 | 赛默飞世尔 map1lc3b抗体(Thermo Scientific, PA1-46286)被用于. Methods (2015) ncbi | |
domestic rabbit 多克隆 | 赛默飞世尔 map1lc3b抗体(Thermo Fisher Scientific, PA1-16931)被用于. Mol Neurobiol (2015) ncbi |
文章列表
- Gao Y, Zhuang Z, Gao S, Li X, Zhang Z, Ye Z, et al. Tetrahydrocurcumin reduces oxidative stress-induced apoptosis via the mitochondrial apoptotic pathway by modulating autophagy in rats after traumatic brain injury. Am J Transl Res. 2017;9:887-899 pubmed
- Cai Y, Yang L, Hu G, Chen X, Niu F, Yuan L, et al. Regulation of morphine-induced synaptic alterations: Role of oxidative stress, ER stress, and autophagy. J Cell Biol. 2016;215:245-258 pubmed
- Zou P, Liu L, Zheng L, Payne K, Manjili M, Idowu M, et al. Coordinated Upregulation of Mitochondrial Biogenesis and Autophagy in Breast Cancer Cells: The Role of Dynamin Related Protein-1 and Implication for Breast Cancer Treatment. Oxid Med Cell Longev. 2016;2016:4085727 pubmed
- Vodicka P, Chase K, Iuliano M, Tousley A, Valentine D, Sapp E, et al. Autophagy Activation by Transcription Factor EB (TFEB) in Striatum of HDQ175/Q7 Mice. J Huntingtons Dis. 2016;5:249-260 pubmed
- Lin M, Liu H, Xiong Q, Niu H, Cheng Z, Yamamoto A, et al. Ehrlichia secretes Etf-1 to induce autophagy and capture nutrients for its growth through RAB5 and class III phosphatidylinositol 3-kinase. Autophagy. 2016;12:2145-2166 pubmed
- Ando K, Tomimura K, Sazdovitch V, Suain V, Yilmaz Z, Authelet M, et al. Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease. Neurobiol Dis. 2016;94:32-43 pubmed 出版商
- Ruparelia A, Oorschot V, Ramm G, Bryson Richardson R. FLNC myofibrillar myopathy results from impaired autophagy and protein insufficiency. Hum Mol Genet. 2016;25:2131-2142 pubmed
- Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
- Medina D, Di Paola S, Peluso I, Armani A, De Stefani D, Venditti R, et al. Lysosomal calcium signalling regulates autophagy through calcineurin and ​TFEB. Nat Cell Biol. 2015;17:288-99 pubmed